Navin Fluorine International update upcoming cGMP-4 facility at Dewas

Navin Fluorine International announced that Phase 1 of cGMP-4 with a capital expenditure of ~ Rs. 160 crore has achieved commissioning readiness today with validation batches having commenced for the company's European partner. The aforesaid refers to the capital expenditure of Rs. 288 crore for new cGMP-4 facility at Dewas.

Powered by Capital Market - Live News